Literature DB >> 9889105

Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice.

D E Barnes1, G Stamp, I Rosewell, A Denzel, T Lindahl.   

Abstract

DNA ligase IV is the most recently identified member of a family of enzymes joining DNA strand breaks in mammalian cell nuclei [1] [2]. The enzyme occurs in a complex with the XRCC4 gene product [3], an interaction mediated via its unique carboxyl terminus [4] [5]. Cells lacking XRCC4 are hypersensitive to ionising radiation and defective in V(D)J recombination [3] [6], implicating DNA ligase IV in the pathway of nonhomologous end-joining (NHEJ) of DNA double-strand breaks mediated by XRCC4, the Ku70/80 heterodimer and the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) in mammalian cells (reviewed in [7]). The phenotype of a null mutant of the Saccharomyces cerevisiae DNA ligase IV homologue indicates that the enzyme is non-essential and functions in yeast NHEJ [8] [9] [10]. Unlike other mammalian DNA ligases for which cDNAs have been characterised, DNA ligase IV is encoded by an intronless gene (LIG4). Here, we show that targeted disruption of LIG4 in the mouse leads to lethality associated with extensive apoptotic cell death in the embryonic central nervous system. Thus, unlike Ku70/80 and DNA-PKcs [11] [12] [13] [14], DNA ligase IV has an essential function in early mammalian development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9889105     DOI: 10.1016/s0960-9822(98)00021-9

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  160 in total

1.  Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice.

Authors:  B Deans; C S Griffin; M Maconochie; J Thacker
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction.

Authors:  Juren Huang; William S Dynan
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

Review 3.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

4.  DNA repair on the brain.

Authors:  R R Laposa; J E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

5.  DNA end joining becomes less efficient and more error-prone during cellular senescence.

Authors:  Andrei Seluanov; David Mittelman; Olivia M Pereira-Smith; John H Wilson; Vera Gorbunova
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-28       Impact factor: 11.205

6.  Oxidative damage and defective DNA repair is linked to apoptosis of migrating neurons and progenitors during cerebral cortex development in Ku70-deficient mice.

Authors:  Roopashree Narasimhaiah; Alexander Tuchman; Stanley L Lin; Janice R Naegele
Journal:  Cereb Cortex       Date:  2004-09-01       Impact factor: 5.357

7.  Double-strand break repair plays a role in repeat instability in a fragile X mouse model.

Authors:  Inbal Gazy; Bruce Hayward; Svetlana Potapova; Xiaonan Zhao; Karen Usdin
Journal:  DNA Repair (Amst)       Date:  2018-12-21

8.  Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.

Authors:  Erin R P Shull; Youngsoo Lee; Hironobu Nakane; Travis H Stracker; Jingfeng Zhao; Helen R Russell; John H J Petrini; Peter J McKinnon
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

9.  p53 Deficiency rescues neuronal apoptosis but not differentiation in DNA polymerase beta-deficient mice.

Authors:  Noriyuki Sugo; Naoko Niimi; Yasuaki Aratani; Keiko Takiguchi-Hayashi; Hideki Koyama
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  BRCA2 is required for neurogenesis and suppression of medulloblastoma.

Authors:  Pierre-Olivier Frappart; Youngsoo Lee; Jayne Lamont; Peter J McKinnon
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.